Stockreport

Organon reports positive phase 3 results on Roche Perjuta biosimilar [Seeking Alpha]

Organon & Co.  (OGN) 
PDF That endpoint was the total pathological complete response (tpCR). Secondary endpoints still under evaluation include tpCR rate assessed by investigators; breast pathol [Read more]